company background image
RPID logo

Rapid Micro Biosystems NasdaqCM:RPID Stock Report

Last Price

US$3.10

Market Cap

US$130.4m

7D

62.3%

1Y

226.3%

Updated

06 Feb, 2025

Data

Company Financials +

Rapid Micro Biosystems, Inc.

NasdaqCM:RPID Stock Report

Market Cap: US$130.4m

RPID Stock Overview

A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. More details

RPID fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Revenue is forecast to grow 18.45% per year

Risk Analysis

Volatile share price over the past 3 months compared to the US market

Currently unprofitable and not forecast to become profitable over the next 3 years


My Notes

Capture your thoughts, links and company narrative

Rapid Micro Biosystems, Inc. Competitors

Harvard Bioscience

NasdaqGM:HBIO

US$72.4m

Champions Oncology

NasdaqCM:CSBR

US$151.0m

Bioqual

OTCPK:BIOQ

US$53.7m

Akoya Biosciences

NasdaqGS:AKYA

US$133.8m

Price History & Performance

Summary of share price highs, lows and changes for Rapid Micro Biosystems
Historical stock prices
Current Share PriceUS$3.10
52 Week HighUS$3.15
52 Week LowUS$0.58
Beta1.27
1 Month Change198.08%
3 Month Change146.03%
1 Year Change226.32%
3 Year Change-62.52%
5 Year Changen/a
Change since IPO-85.51%

Recent News & Updates

Investors Still Aren't Entirely Convinced By Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Revenues Despite 27% Price Jump

Jan 16
Investors Still Aren't Entirely Convinced By Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Revenues Despite 27% Price Jump

Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Shares Leap 25% Yet They're Still Not Telling The Full Story

Nov 02
Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Shares Leap 25% Yet They're Still Not Telling The Full Story

Recent updates

Investors Still Aren't Entirely Convinced By Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Revenues Despite 27% Price Jump

Jan 16
Investors Still Aren't Entirely Convinced By Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Revenues Despite 27% Price Jump

Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Shares Leap 25% Yet They're Still Not Telling The Full Story

Nov 02
Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) Shares Leap 25% Yet They're Still Not Telling The Full Story

Is Rapid Micro Biosystems (NASDAQ:RPID) In A Good Position To Invest In Growth?

Oct 29
Is Rapid Micro Biosystems (NASDAQ:RPID) In A Good Position To Invest In Growth?

A Piece Of The Puzzle Missing From Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 32% Share Price Climb

Aug 03
A Piece Of The Puzzle Missing From Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) 32% Share Price Climb

We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Jun 30
We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Rapid Micro to introduce RMBNucleus software for mold detection in pharma manufacturing

Oct 10

Companies Like Rapid Micro Biosystems (NASDAQ:RPID) Are In A Position To Invest In Growth

May 09
Companies Like Rapid Micro Biosystems (NASDAQ:RPID) Are In A Position To Invest In Growth

Earnings Release: Here's Why Analysts Cut Their Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Price Target To US$17.67

Mar 08
Earnings Release: Here's Why Analysts Cut Their Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Price Target To US$17.67

We're Not Very Worried About Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Feb 07
We're Not Very Worried About Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Shareholder Returns

RPIDUS Life SciencesUS Market
7D62.3%0.2%0.6%
1Y226.3%-4.8%22.4%

Return vs Industry: RPID exceeded the US Life Sciences industry which returned -4.8% over the past year.

Return vs Market: RPID exceeded the US Market which returned 22.4% over the past year.

Price Volatility

Is RPID's price volatile compared to industry and market?
RPID volatility
RPID Average Weekly Movement17.1%
Life Sciences Industry Average Movement8.5%
Market Average Movement6.4%
10% most volatile stocks in US Market18.8%
10% least volatile stocks in US Market3.2%

Stable Share Price: RPID's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: RPID's weekly volatility has increased from 11% to 17% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006193Rob Spignesiwww.rapidmicrobio.com

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables.

Rapid Micro Biosystems, Inc. Fundamentals Summary

How do Rapid Micro Biosystems's earnings and revenue compare to its market cap?
RPID fundamental statistics
Market capUS$130.39m
Earnings (TTM)-US$48.39m
Revenue (TTM)US$26.17m

5.1x

P/S Ratio

-2.8x

P/E Ratio

Is RPID overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RPID income statement (TTM)
RevenueUS$26.17m
Cost of RevenueUS$27.43m
Gross Profit-US$1.26m
Other ExpensesUS$47.13m
Earnings-US$48.39m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.12
Gross Margin-4.82%
Net Profit Margin-184.93%
Debt/Equity Ratio0%

How did RPID perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 00:10
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Rapid Micro Biosystems, Inc. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tycho PetersonJ.P. Morgan
Tejas SavantMorgan Stanley
Daniel AriasStifel, Equities Research